Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Recruiting

Phase 3

TradipitantEvaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Sponsor:

Vanda Pharmaceuticals

Code:

NCT04028492

Conditions

Idiopathic Gastroparesis

Diabetic Gastroparesis

Gastroparesis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Tradipitant

Placebo

Open Label Tradipitant

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Vanda Pharmaceuticals on 2024-03-22.